Perrigo reported $0.5 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 0.56 0.80 Nov/11
FY2026Q2 Jun/2026 0.50 0.34 0.57 Aug/05
FY2026Q1 Mar/2026 0.43 0.33 0.60 May/06
FY2025Q4 Dec/2025 0.77 0.79 0.36 Feb/26
FY2025Q3 Sep/2025 0.80 0.76 0.81 Nov/05




Eps Change Date
AbbVie USD 3.65 1 Jun/2026
Abbott USD 1.31 0.16 Jun/2026
Bayer EUR 0.95 1.76 Jun/2026
Bristol-Myers Squibb USD 2.04 0.46 Jun/2026
Coherus Biosciences USD -0.43 0.06 Dec/2025
Corcept Therapeutics USD 0.36 0.66 Jun/2026
Dr.Reddys Laboratories INR 5.33 0.47 Jun/2026
Eli Lilly USD 8.38 0.17 Jun/2026
J&J USD 2.9 0.2 Jun/2026
Merck USD -0.13 1.15 Jun/2026
Nestle CHF 2.11 0.03 Jun/2026
Pacira USD 0.73 0.13 Jun/2026
Perrigo USD 0.5 0.07 Jun/2026
Pfizer USD 0.77 0.02 Jun/2026
Phibro Animal Health USD 0.78 0.1 Dec/2025
Prestige Brands USD 1.23 0.09 Mar/2026
Reckitt Benckiser GBP 1.84 0.43 Dec/2025
Sanofi EUR 2.09 0.21 Jun/2026
Supernus Pharmaceuticals USD -1.01 1.61 Jun/2026
Teva Pharmaceutical Industries USD 0.06 1.51 Jun/2026
Xeris Pharmaceuticals USD 0.01 0.04 Mar/2026
Zoetis USD 1.53 0.05 Mar/2026